IL32 and metabolic dysfunction-associated steatohepatitis: Immune activation can also be observed on a transcriptional level: A study in severely obese patients with NASH and/or significant fibrosis found interleukin 32 to be the most heavily upregulated transcript, and circulating interleukin 32 levels corresponded to the expression in the liver tissue [63].